Exolvo Biosciences
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Research, Med Tech |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Exolvo Biosciences
Brian Longstreet
Co-Founder & CEO
Exolvo Biosciences Email Formats
Exolvo Biosciences uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@exolvobio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@exolvobio.com | 100% |
About Exolvo Biosciences
Exolvo Biosciences is an innovative biotech company leading the way in transforming the oral delivery of large, complex molecules. Applying technology incubated within Verily/Google, Exolvo is committed to revolutionizing biologic drug delivery, making treatments more accessible and less invasive for patients. With a focus on pioneering solutions in an area that has seen limited advancements, Exolvo aims to improve patient outcomes and healthcare efficiency globally.
Exolvo Biosciences revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Exolvo Biosciences has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Exolvo Biosciences has never raised funding before.
Exolvo Biosciences Tech Stack
Discover the technologies and tools that power Exolvo Biosciences's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Databases
Programming languages
Blogs
WordPress themes
Page builders
Miscellaneous
Performance
Font scripts
JavaScript libraries
Germany
France
Austria
Canada
Frequently asked questions
4.8
40,000 users
